XELJANZ 1 mg/mL

XELJANZ 1 mg/mL is an oral solution containing tofacitinib, used for managing certain inflammatory conditions. This medication is designed to help reduce symptoms and improve quality of life for eligible patients.

XELJANZ 1 mg/mL is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Tofacitinib, the active ingredient, works by modulating the immune system to reduce inflammation. Patients often wonder, 'What is XELJANZ used for?' and it is generally prescribed to alleviate symptoms and slow disease progression in these conditions.

Common effects of XELJANZ 1 mg/mL may include nausea, diarrhea, and upper respiratory infections. Some users might experience headaches or increased susceptibility to infections. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

XELJANZ 1 mg/mL should be handled with care, especially by individuals with a history of infections or blood clots. Regular monitoring is advised to manage potential side effects. Always follow the guidance of a healthcare professional when using this medication.

XELJANZ 1 mg/mL may interact with certain medications, including those that affect the immune system or blood clotting. Alcohol and other immunosuppressants should be used cautiously. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.